News Image

Compugen Reports First Quarter 2025 Results

Provided By PR Newswire

Last update: May 19, 2025

HOLON, Israel, May 19, 2025 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today reported financial results for the first quarter of 2025 and provided a corporate update.

Read more at prnewswire.com

COMPUGEN LTD

NASDAQ:CGEN (7/23/2025, 8:10:38 PM)

Premarket: 1.57 0 (0%)

1.57

+0.02 (+1.29%)



Find more stocks in the Stock Screener

Follow ChartMill for more